Medical Equipment

Automated Compounding Devices Market Future Analysis Covering Industry Shifts And Growth Potential

May 11, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Automated Compounding Devices Market By 2030 Based On Its 2026 Value?

The automated compounding devices market has experienced significant expansion recently. This market is projected to expand from $2.51 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. The historical growth can be linked to factors such as an increasing workload in hospital pharmacies, a heightened demand for sterile iv preparations, the early implementation of tpn compounding automation, hospital-led efforts to minimize compounding errors, and a rise in inpatient medication therapy volumes.

The automated compounding devices market size is projected to experience substantial expansion over the coming years, reaching $3.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period is primarily driven by a heightened focus on medication safety compliance, increased investments in automated pharmacy technology, a rise in the outsourcing of sterile compounding services, the broadening scope of oncology and critical care drug compounding, and the expanding integration of digital workflow and reporting systems. Key trends anticipated in this period include a greater uptake of automated compounding devices to mitigate manual medication preparation errors in hospital and pharmacy environments, an escalating demand for high-precision compounding of IV formulations, oncology drugs, and TPN solutions, a developing transition towards centralized and large-volume sterile compounding facilities across healthcare systems, a widening application of automated workflow validation and barcode-based verification in compounding procedures, and a growing preference for compact, modular, and upgradeable automated compounding platforms for pharmacy operations.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

What Key Growth Drivers Are Influencing The Automated Compounding Devices Market?

A rise in personalized medicines is anticipated to propel the expansion of the automated compounding devices market in the future. Personalized medicine describes a healthcare strategy where decisions, methods, actions, and therapies are customized to meet the unique characteristics of every patient. The growing prevalence of personalized medicines stems from enhanced genetic comprehension, specific patient information, and supportive regulations. Automated compounding devices (ACDs) are vital in personalized medicine, facilitating the precise and accurate creation of custom medication formulas that match individual patient requirements. Such devices automate the blending of different pharmaceutical components in exact ratios, which is fundamental for developing tailored treatments. For example, data from February 2024, provided by the Personalized Medicine Coalition, a US-based non-profit organization, shows that the FDA cleared 16 new personalized therapies for rare disease patients in 2023, an increase from six in 2022. Consequently, the growing volume of personalized medicines is boosting the expansion of the automated compounding devices market.

How Does Segment Analysis Break Down The Automated Compounding Devices Market Structure?

The automated compounding devices market covered in this report is segmented –

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software

2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems

3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems

4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)

2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

What Trends Are Shaping The Automated Compounding Devices Market Structure?

Major companies operating in the automated compounding devices market are prioritizing AI-driven robotic compounding, such as AI-enabled IV compounding platforms systems that leverage artificial intelligence, gravimetric verification, and cloud-based monitoring to automate sterile admixture preparation with high precision, real-time quality assessments, and continuous oversight. For example, in August 2025, Omnicell, a US-based health-technology company, launched an AI-enhanced upgrade to its IV compounding system, designed to bolster safety and accuracy in medication preparation. The updated system integrates sophisticated AI-based quality-assurance tools that continuously supervise compounding activities, automatically detecting and flagging any departures from expected procedures. By implementing this level of automated oversight, Omnicell aims to mitigate human error, enhance workflow efficiency, and support elevated standards of medication quality in pharmacy operations.

Which Companies Are Influencing The Automated Compounding Devices Market?

Major companies operating in the automated compounding devices market are Becton Dickinson and Company, Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Fagron NV, Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group SPA, ARxIUM Inc., Codonics Inc., Equashield LLC, Yuyama Mfg Co Ltd, Shanghai Weibond Technology Co Ltd, Medimpex LLC, Medica Inc

Access The Complete Automated Compounding Devices Market Report:

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Which Region Stands As The Largest Contributor To The Automated Compounding Devices Market?

North America was the largest region in the automated compounding devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Automated Compounding Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp

Browse Through More Reports Similar to the Global Automated Compounding Devices Market 2026, By The Business Research Company

Plastic Compounding Market Report 2026

https://www.thebusinessresearchcompany.com/report/plastic-compounding-global-market-report

Compound Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/compound-management-global-market-report

Electronic Products Market 2026

https://www.thebusinessresearchcompany.com/report/electronic-products-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795